Catalyst Wire Dossier Catalyst Wire Dossier

Trifarotene Cream 0.005%

trifarotene · Sun Pharmaceutical Industries, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Trifarotene Cream 0.005%, covering 2024-09-26 to 2024-12-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris [Phase 1]

See pricing